Pacemakers are medical devices used to deliver electrical pulses to the heart, in order to maintain a normal heart rate. These devices are used for the treat heart medical complications/conditions such as arrhythmias and heart failure.
The Pacemakers market size was worth $ XX billion in 2018 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period.
The Pacemakers market growth is driven by several factors such as, rising prevalence of heart diseases, favorable reimbursement scenario, growing geriatric population, and technological advancements in the devices.
The Pacemaker market is also growing due to rising advancements in pacemaker technologies over the past few years. One of the biggest trends in the pacemaker technology is battery free pacemaker. Pacemakers rely on bulky batteries, which have to be swapped out at regular intervals due to their short lifespans. To overcome the challenge, in April 2019, researchers from China and the U.S. developed an alternative battery-free pacemaker which gathers its required electricity from the energy of heartbeats.
On the basis of technology, the Pacemaker market is segmented into:
• Single chamber pacemaker
• Dual-chamber pacemaker
• Biventricular/CRT pacemaker
Single-chamber pacemaker has one lead that connects the pulse generator to one chamber of the heart. Dual-chamber pacemaker is a device with two leads which regulates the pace of contractions of both chambers. The dual-chamber pacemakers held significant market share in 2018, owing to some factors such as reduced post-surgical complications and presence of two leads in order to assure normal physiology of the heart.
On the basis of application, the Pacemakers market is segmented into:
• Atrial Fibrillation
• Bradycardia
• Arrhythmia
• Tachycardia
Among these, Atrial fibrillation holds a significant market share over the forecast period (2019-2026). Atrial fibrillation, often called AFib or AF, is the most common type of heart arrhythmia.
North America is dominating the Pacemakers market in 2018 and estimated to hold largest market size over the forecast period (2019-2026), owing to the rising prevalence of cardiovascular disease, high obesity rates, and a favorable reimbursement environment.
By geography, the Tissue Paper market is segmented into:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: